What is Hunan Warrant Pharmaceutical Co.,Ltd's (688799.SS) StockRank?

MoatMap's StockRank for Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) is 50/100, with a Hold signal. This is a composite score combining Quality (62), Value (27), and Momentum (52) factor ranks across MoatMap's 19,000+ stock universe.

Does Hunan Warrant Pharmaceutical Co.,Ltd have an economic moat?

Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) has a Quality factor score of 62/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Hunan Warrant Pharmaceutical Co.,Ltd a buy, hold, or sell?

MoatMap's current signal for Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) is Hold, based on a StockRank of 50/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Hunan Warrant Pharmaceutical Co.,Ltd in?

Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688799.SS

HOLDFLAG

Hunan Warrant Pharmaceutical Co.,Ltd · Healthcare · China · $975M · Avg Vol: $23M/d

StockRank

P/E (TTM)

29.0x

ROE

11.0%

D/E

0.3x

Dividend %

0.4%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

A high-quality Chinese pharmaceutical and API manufacturer with solid domestic market share. However, its heavy domestic focus limits its ability to capture global CDMO pricing power, and it lacks the asymmetric global upside we require.

COMPANY DESCRIPTION

Hunan Warrant Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical company engaged in the R&D, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dosage formulations. The company holds a strong market position in China's digestive, cardiovascular, and pediatric therapeutic segments. Its competitive moat is sustained by its integrated 'API + formulation' business model, which ensures cost efficiency and regulatory compliance.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	191M	212M	209M	222M	5.2%
EPS	0.21	0.24	0.18	0.27	9.1%
Shares	131M	131M	131M	131M	0.0%
Debt	52M	3M	17M	74M	12.4%
Equity	236M	255M	267M	302M	8.6%
Op CF	23M	32M	21M	44M	24.5%
Inv CF	-34M	6M	-53M	-90M	—
Fin CF	-11M	-8M	2M	50M	—

PRICE (1M)-18.3%

SMA 50SMA 200

$6.86

RSI (14)

30.5

52W High

$9.88

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

9.1%70.8

ROE

11.0%74.6

GP/Assets

28.9%63.5

Op. Margin

11.7%69.5

FCF/Assets

-5.5%35.1

Piotroski

—83.5

Int. Cover

50.0x91.4

D/E Ratio

0.32x41.5

Current Ratio

2.83x50.6

Value

P/E (TTM)

29.0x38.2

EV/EBITDA

30.5x11.4

P/FCF

—N/A

P/B

3.0x38.9

P/S

4.3x45.3

Div Yield

0.4%10.9

Momentum

52W High %

69%56.2

RS 6M

-11%67.4

SMA 50/200

1.08x77.1

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-35%15.8

FUNDAMENTALS

Market Cap

$975M

P/E (Forward)

—

Gross Margin

59.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688799.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688799.SS	Hunan Warrant Pharmaceutical Co.,Ltd(you)	$975M	50	HOLD
688505.SS	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	$1.1B	52	HOLD
300401.SZ	Zhejiang Garden Biopharmaceutical Co.,Ltd.	$984M	54	HOLD
301393.SZ	Suzhou Highfine Biotech Co., Ltd.	$896M	55	HOLD
600789.SS	Shandong Lukang Pharmaceutical Co.,Ltd.	$1.2B	48	HOLD
688117.SS	ChengDu ShengNuo Biotec Co.,Ltd.	$785M	48	HOLD
300119.SZ	Tianjin Ringpu Bio-Technology Co.,Ltd.	$1.1B	55	HOLD
000813.SZ	Dezhan Healthcare Company Limited	$1.0B	42	HOLD
600829.SS	HPGC Renmintongtai Pharmaceutical Corporation	$746M	46	HOLD
603538.SS	Ningbo Menovo Pharmaceutical Co., Ltd.	$1.6B	51	HOLD

Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.0%

Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) — Stock Score Summary

Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) has a MoatMap StockRank of 50/100 based on Quality (62/100), Value (27/100), and Momentum (52/100) factor scores. The current signal is HOLD. A high-quality Chinese pharmaceutical and API manufacturer with solid domestic market share. However, its heavy domestic focus limits its ability to capture global CDMO pricing power, and it lacks the asymmetric global upside we require.

Key Financial Metrics

Price	$6.86
Market Cap	$975M
P/E (TTM)	28.99
Price/Book	3.04
Return on Equity	11.0%
Return on Invested Capital	9.1%
Debt/Equity	32.40
Gross Margin	59.0%
Operating Margin	11.7%
Revenue Growth	-3.5%
Dividend Yield	0.4%
Free Cash Flow	$-4M

Hunan Warrant Pharmaceutical Co.,Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Hunan Warrant Pharmaceutical Co.,Ltd’s (688799.SS) StockRank?: MoatMap’s StockRank for Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) is 50/100, with a Hold signal. It is a composite of Quality (62), Value (27), and Momentum (52) factor ranks across MoatMap’s 19,000+ stock universe.
Does Hunan Warrant Pharmaceutical Co.,Ltd have an economic moat?: Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) has a Quality factor score of 62/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Hunan Warrant Pharmaceutical Co.,Ltd a buy, hold, or sell?: MoatMap’s current signal for Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) is Hold, based on a StockRank of 50/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Hunan Warrant Pharmaceutical Co.,Ltd in?: Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).